[PSYCHOPHARMOCOLOGIC ANIMAL STUDY AND CLINICAL ANTIDEPRESSIVE TRIALS WITH A NEW AUXIN DERIVATIVE: MEPHEXAMIDE (ANP 297)].
D000818:Animals; D000928:Antidepressive Agents; D001007:Anxiety; D001247:Asthenia; D009320:Atrial Natriuretic Factor; D035843:Biomedical Research; D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D004827:Epilepsy; D006168:Guinea Pigs; D000882:Haplorhini; D007210:Indoleacetic Acids; D051379:Mice; D009069:Movement Disorders; D009449:Neurocirculatory Asthenia; D009497:Neurotic Disorders; D010600:Pharmacology; D014116:Toxicology
D000928:Antidepressive Agents; D007210:Indoleacetic Acids; D009320:Atrial Natriuretic Factor
ANTIDEPRESSIVE AGENTS; ANXIETY; ASTHENIA; CLINICAL RESEARCH; DEPRESSION; DRUG THERAPY; EPILEPSY; GUINEA PIGS; MICE; MONKEYS; MOVEMENT DISORDERS; NEUROCIRCULATORY ASTHENIA; NEUROSES; PHARMACOLOGY; TOXICOLOGIC REPORT
ETUDE PSYCHO-PHARMACOLOGIQUE ANIMALE ET ASSAIS CLINIQUES ANTID'EPRESSEURS D'UN NOUVEAU D'ERIV'E AUXINIQUE: LE M'EFEXAMIDE (A.N.P. 297)